Loteprednol Etabonate D5
Code | Size | Price |
---|
TAR-T11871-100mg | 100mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T11871-500mg | 500mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20°C
Images
Documents
Further Information
Bioactivity:
Loteprednol Etabonate D5 is a deuterium labeled Loteprednol etabonate.Loteprednol etabonate (LE) exhibits anti-inflammatory activity and has been used in optometry and ophthalmology. Loteprednol etabonate (LE) is an orally active soft steroid belonging to a unique class of glucocorticoids.
CAS:
2026643-11-6
Formula:
C24H31ClO7
Molecular Weight:
471.98
Purity:
0.98
SMILES:
O(C(OC(C([2H])([2H])[2H])([2H])[2H])=O)[C@@]1(C(OCCl)=O)[C@]2(C)[C@@](CC1)([C@]3([C@]([C@@H](O)C2)([C@]4(C)C(CC3)=CC(=O)C=C4)[H])[H])[H]
References
Pavesio CE, Decory HH. Treatment of ocular inflammatory conditions with loteprednol etabonate. Br J Ophthalmol. 2008 Apr;92(4):455-9.
Comstock TL, Decory HH. Advances in corticosteroid therapy for ocular inflammation: loteprednol etabonate. Int J Inflam. 2012;2012:789623.
Howes JF. Loteprednol etabonate: a review of ophthalmic clinical studies. Pharmazie. 2000 Mar;55(3):178-83.